Azim Premji is an early investor in US firm Moderna, a frontrunner in making Covid-19 vaccine
Team Udayavani, May 21, 2020, 7:17 PM IST
Wipro founder and chairman Azim Premji is an early investor in US-based Moderna, which is working on an experimental Covid-19 vaccine
The investment happened via PremjiInvest, his private investment arm which manages billions of dollars in assets
Dhiraj Malkani, a partner at Premji Invest in Boston also recently shared news about their portfolio company Moderna on his LinkedIn page.
Sources claim that Premji Invest invested $25-30 million in the company a few years ago. Premji Invest has also placed its bets on other US-based healthtech companies such as Devoted Health, Iora Health and Grand Rounds.
Moderna is at the forefront of the COVID-19 vaccine race. The NASDAQ-listed company had recently announced positive data from the phase 1 of its vaccine testing in the United States
According to early results released by the company, Moderna’s vaccine has produced protective antibodies in a small group of healthy volunteers.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Kotak Mahindra Bank shares tank 13%; mcap erodes by Rs 37,721 crore post RBI action
Four-day market rally makes investors richer by Rs 8.48 lakh crore
Kotak Bank barred from onboarding customers online, issuing fresh credit cards
Reverse migration has begun, says FM Nirmala Sitharaman
Markets sustain winning streak — Sensex jumps over 560 points, Nifty tops 22,300-level
MUST WATCH
Latest Additions
NIA arrests key accused in 2023 attack on Indian High Commission in London
Three persons run over by train in Bengaluru
Indian nationals aboard ‘MSC Aries’ in good health, return delayed due to technicalities: MEA
Husband has no control over wife’s ‘stridhan’: SC
IT sleuths threatening raided leaders to claim money belongs to me, Cong: DK Shivakumar